Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis
Masahiro Miura,1,2 Takuya Iwasaki,1,2 Hiroshi Goto2 1Department of Ophthalmology, Tokyo Medical University, Ibaraki Medical Center, Ami, Ibaraki, Japan; 2Department of Ophthalmology, Tokyo Medical University, Nishi-Shinjuku, Tokyo, Japan Purpose: To evaluate the effect of aflibercept treatment after...
Enregistré dans:
Auteurs principaux: | Miura M, Iwasaki T, Goto H |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2d8bb254aaf643469d67269acdc1e29a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Response of serous retinal pigment epithelial detachments to intravitreal aflibercept in polypoidal choroidal vasculopathy refractory to ranibizumab
par: Yamashita M, et autres
Publié: (2014) -
Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy
par: Nemoto R, et autres
Publié: (2012) -
Efficacy of intravitreal aflibercept injections for Japanese patients with polypoidal choroidal vasculopathy
par: Arakawa A, et autres
Publié: (2017) -
One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy
par: Sakurai M, et autres
Publié: (2014) -
Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy
par: Kitahashi M, et autres
Publié: (2014)